Related references
Note: Only part of the references are listed.Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and Management
Ali K. Abu-Alfa et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus
Mitchell S. Cairo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
A Patient with Advanced Hepatocellular Carcinoma Treated with Sorafenib Tosylate Showed Massive Tumor Lysis with Avoidance of Tumor Lysis syndrome
Satoru Joshita et al.
INTERNAL MEDICINE (2010)
Tumor lysis syndrome associated with carboplatin and paclitaxel in a woman with recurrent endometrial cancer
Heidi Godoy et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2010)
Managing tumor lysis syndrome in 2010
Morie A. Gertz
LEUKEMIA & LYMPHOMA (2010)
Mechanisms of Disease: Genetic Disorders of Renal Phosphate Transport.
Dominique Prie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Drug Therapy: Oral Phosphate Binders in Patients with Kidney Failure.
Marcello Tonelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME AND MULTIPLE ORGAN DYSFUNCTION IN PATIENTS WITH ACUTE TUMOR LYSIS SYNDROME
Marcio Soares et al.
CLINICS (2009)
Catastrophic tumour lysis syndrome following single dose of imatinib
Colm Keane et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Tumor Lysis Syndrome in Solid Tumors
Cengiz Gemici
JOURNAL OF CLINICAL ONCOLOGY (2009)
A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome
Michiko Shimada et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Ching-Hon Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The role of hypercytokinemia in the pathophysiology of tumor lysis syndrome (TLS) and the treatment with continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF)
Masataka Nakamura et al.
TRANSFUSION AND APHERESIS SCIENCE (2009)
Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient
Wu-Shiung Huang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout - Results of a phase II randomized study
John S. Sundy et al.
ARTHRITIS AND RHEUMATISM (2008)
Rasburicase: future directions in tumor lysis management
Jessica Hochberg et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Fatal Tumor Lysis Syndrome During Radiotherapy for Non-Small-Cell Lung Cancer
Geum Youb Noh et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Management of Tumor Lysis Syndrome: Need for Evidence-Based Guidelines
James H. Feusner et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cetuximab-related tumor lysis syndrome in metastatic colon carcinoma
Ganapathy Krishnan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Guidelines for the management of pediatric and adult tumor lysis syndrome: An evidence-based review
Bertrand Coiffier et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Uric acid and cardiovascular risk
Daniel I. Feig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model
Pau Montesinos et al.
HAEMATOLOGICA (2007)
Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome
Tony H. Truong et al.
CANCER (2007)
Acute renal failure from xanthine nephropathy during management of acute leukemia
Christopher LaRosa et al.
PEDIATRIC NEPHROLOGY (2007)
Emerging drugs for hyperphosphatemia
Guido Bellinghieri et al.
EXPERT OPINION ON EMERGING DRUGS (2007)
Uric acid as inducer of calcium oxalate crystal development
Felix Grases et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2007)
Could uric acid have a role in acute renal failure?
A. Ahsan Ejaz et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
A predictive model for the detection of tumor lysis syndrome during AML induction therapy
Anthony R. Mato et al.
LEUKEMIA & LYMPHOMA (2006)
Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia
N Hijiya et al.
PEDIATRIC BLOOD & CANCER (2005)
Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek (TM)), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial
S Jeha et al.
LEUKEMIA (2005)
Tumour lysis syndrome: new therapeutic strategies and classification
MS Cairo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Growth of calcium oxalate monohydrate on uric acid crystals at sustained supersaturation
C Bouropoulos et al.
CRYSTAL RESEARCH AND TECHNOLOGY (2004)
Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis dose
JP Gutzwiller et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial
CH Pui et al.
LEUKEMIA (2001)
A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis
SC Goldman et al.
BLOOD (2001)
Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration
HK Tan et al.
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS (2001)
Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma
CH Pui et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)